NCIt definition : A statin with antilipidemic and potential antineoplastic activities. Rosuvastatin
selectively and competitively binds to and inhibits hepatic hydroxymethyl-glutaryl
coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA
to mevalonate, a precursor of cholesterol. This leads to a decrease in hepatic cholesterol
levels and increase in uptake of LDL cholesterol. In addition, rosuvastatin, like
other statins, exhibits pro-apoptotic, growth inhibitory, and pro-differentiation
activities in a variety of tumor cell types; these antineoplastic activities may be
due, in part, to inhibition of the isoprenylation of Ras and Rho GTPases and related
signaling cascades.;
UNII : 413KH5ZJ73;
InChIKey : BPRHUIZQVSMCRT-VEUZHWNKSA-N;
CAS number : 287714-41-4; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 287714-41-4
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;